Please contact us for more information or to learn if you are eligible to participate.
To evaluate the safety and tolerability of once-daily, oral administration of 80 or 100 mg resmetirom versus matching placebo
Fernando Membreno, MD
Madrigal Pharmaceuticals, Inc
Type of Trial